|
Summary of selected patient responses to the SOQ |
|
| Effect of treatment on time commitment |
|
| Mean (SD) travel time to/from the clinic |
60 (48) minutes per visit |
| Mean (SD) waiting time at the clinic |
18 (24) minutes per visit |
| Effect of treatment on patient attitude |
|
| Attitude towards travel for treatment during first chemotherapy cycle |
Moderately to extremely bothered, 45% |
| Attitude towards travel for treatment during second chemotherapy cycle |
Moderately to extremely bothered, 59% |
| Disruption of daily activities caused by injection frequency |
Reported disruption some to all of the time, 44% |
| Disruption of work schedule caused by injection frequency |
Took time off from work for treatment some to all of the time, 18% |
| Effect of treatment on patient satisfaction and drug preference |
|
| Experience with Filgrastim therapy after most recent chemotherapy cycle |
Moderately to very much satisfied, > 90% |
| Choice between daily injections versus newer, longer-acting drug |
Preference for new drug, 89% |
Haithcox et al. BMC Nursing 2003 2:2 doi:10.1186/1472-6955-2-2 |
|